AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-32557422_ITM" title="Facts and information about Fibromyalgia Drug Market Will Nearly Quadruple to $2 Billion by 2016.">Fibromyalgia Drug Market Will Nearly Quadruple to $2 Billion by 2016.</a>

Close Set up an RSS feed that alerts you when new articles from PR Newswire are available.

Frequently asked questions about RSS feeds

Fibromyalgia Drug Market Will Nearly Quadruple to $2 Billion by 2016.

PR Newswire

| August 06, 2007 | COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Significant Growth Will be Driven by Regulatory Approval of New Drugs That Will Compete With Pfizer's Lyrica, According to a New Report from Decision Resources

WALTHAM, Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent approval of Pfizer's Lyrica (pregabalin) to treat fibromyalgia and the entry of several new drugs over the next decade will drive the fibromyalgia drug market to nearly quadruple and reach $2 billion in 2016

The new Pharmacor report Fibromyalgia finds that the market to treat the disease, which drug companies have only…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


The Market for Urinary Incontinence Therapies Is Poised for Growth Due to New...: Press release article from: PR Newswire November 29, 1999 700+ words
...recent introduction of new drugs, patient awareness campaigns...UI market dramatically. Decision Resources, Inc., has just published...or.jp (e-mail). Decision Resources, Inc., is a world leader...international network of experts, Decision Resources offers its clients ...


Five New Drugs for the Treatment of Generalized Anxiety Disorder Will Arrive to...: Press release article from: PR Newswire September 22, 2003 700+ words
...PRNewswire/ -- Decision Resources, Inc., one of...forecasts that five new drugs for generalized...Nagle, analyst at Decision Resources. "Moreover, there...About Pharmacor from Decision Resources Pharmacor is a unique...


Viagra to Remain the Top Seller in The Erectile Dysfunction Drug Market...: Press release article from: PR Newswire March 19, 2003 700+ words
...Mass., March 19 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading...new primary research report from Decision Resources. (Photo: http://www.newscom...said Kat Neumeyer, analyst, Decision Resources. "However, health management organizations...


Medicare Part D Rules and Cost-Containment Regulations will Limit Uptake of New...: Press release article from: PR Newswire June 12, 2006 700+ words
...reimbursement, and uptake of new drugs that do not differentiate...Ph.D., analyst at Decision Resources, Inc. "Only new drugs that can show better efficacy...per 1,000 people. About Decision Resources Decision Resources, Inc...


New drugs from Novartis and Daiichi Sankyo will achieve blockbuster status in...: News wire article from: Chemical Business Newsbase March 5, 2007 700+ words
(From Chemical Business NewsBase - Press Release) Decision Resources finds that new drugs from Novartis and Daiichi Sankyo will achieve blockbuster status in the drug market to treat hypertension. The new Pharmacor report...


New drugs from GlaxoSmithKline, Novartis, NicOx, and Pain Therapeutics will...: News wire article from: Chemical Business Newsbase November 30, 2005 700+ words
(From Chemical Business NewsBase - Press Release) Decision Resources Inc finds that new drugs from GlaxoSmithKline, Novartis, NicOx, and Pain Therapeutics...which will be available generically by the time the new drugs are launched.


Five new drugs for the treatment of generalized anxiety disorder will arrive to...: News wire article from: Asia Africa Intelligence Wire September 22, 2003 700+ words
(From Chemical Business NewsBase - Press Release) Decision Resources Inc forecasts that five new drugs for generalized anxiety disorder (GAD) will arrive to market by 2008. Those expected to gain marketing approval for GAD by 2008...


Pharmaceutical and Biotechnology Companies are Turning to Personalized Medicine...: Press release article from: Business Wire March 24, 2006 700+ words
...improve the drug development process and speed the approval of new drugs. This Decision Resources report discusses the role of IVD and molecular diagnostics...www.researchandmarkets.com/reports/c31922 Source: Decision Resources


DecisionBase 9 Reveals the Commercial Opportunity for Drugs in Development in...: Press release article from: PR Newswire April 11, 2005 700+ words
...potential of new drugs. It analyzes...president of Decision Resources. "The profile...input from Decision Resources' staff of...potential, license new drugs, and achieve...success. About Decision Resources Decision Resources...


Eli Lilly's Xigris Could Lead the Way in Revolutionizing the Treatment Of...: Press release article from: PR Newswire November 13, 2001 700+ words
...recent study from Decision Resources, Inc., that examines how new drugs that directly target...and development. Decision Resources, Inc., is a world...years. Visit the Decision Resources Web site at http...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: